Tesamorelin
10mg
Growth hormone-releasing hormone (GHRH) analogue.
Research Profile
About Tesamorelin
Tesamorelin is a synthetic, stabilized analogue of growth hormone-releasing hormone (GHRH), a 44-amino-acid hypothalamic peptide. Structural modifications improve its stability relative to native GHRH, making it a durable tool for growth-hormone-axis research.
It is studied primarily for its ability to stimulate the body’s own (endogenous) growth-hormone production and appears frequently in metabolic and body-composition research. Provided lyophilized for in-vitro and laboratory research only.
Mechanism of Action
Tesamorelin binds GHRH receptors on somatotroph cells of the anterior pituitary, where it is studied for stimulating the pulsatile release of endogenous growth hormone and the downstream production of insulin-like growth factor-1 (IGF-1), preserving the natural feedback rhythm of the GH axis.
Research Applications
- Growth-hormone-axis research
- Visceral-adiposity and body-composition models
- IGF-1 signaling studies
- Metabolic research
Provided for educational and research context only. Tesamorelin is sold strictly for in-vitro laboratory and research use — it is not a drug, supplement, or medical product, is not intended to diagnose, treat, cure, or prevent any disease, and is not for human or veterinary use.
Support
Frequently Asked Questions
Everything you need to know about this product and your order.
